Early measurement of interstitial fibrosis predicts long-term renal function and graft survival in renal transplantation

British Journal of Surgery

Volumn 83, Issue 8, 1996, Pages 1082-1085

  Nicholson, M L ^a   McCulloch, T A ^a   Harper, S J ^a   Wheatley, T J ^a   Edwards, C M ^a   Feehally, J ^a   Furness, P N ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; NIFEDIPINE;

ARTICLE; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029741614     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800830813     Document Type: Article

References (38)

1. Canadian Multicentre Transplant Study Group. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years. N Engl J Med 1986; 314: 1219-25.
2. Calne RY. Cyclosporine in cadaveric renal transplantation: 5 year follow-up of a multicentre trial. Lancet 1987; ii: 506-7.
3. Tilney NL, Whitley WD. Diamond JR, Kupiec-Weglinski JW, Adams DH. Chronic rejection - an undefined conundrum. Transplantation 1991; 52: 389-98.
4. Cook DJ, Terasaki PI. Renal transplantation on the American continent. In: Brent L, Sells RA, eds. Organ Transplantation: Current Clinical and Immunological Concepts. London: Baillière Tindall. 1989: 195-200.
5. Paul LC, Benediktsson H. Chronic transplant rejection: magnitude of the problem and pathogenetic mechanisms. Transplant Rev 1993; 7: 96-104.
6. Foster MC, Wenham PW, Rowe PA et al. The late results of renal transplantation and the importance of chronic rejection as a cause of graft loss. Ann R Coll Surg Engl 1989; 71: 44-7.
7. Halloran P, Aprile M. Factors influencing early renal function in cadaver kidney transplants. A case-control study. Transplantation 1988; 45: 122-7.
8. Basadonna GP, Matas AJ, Gillingham KJ et al. Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation 1993; 55: 993-5.
9. Tesi RJ, Elkhammas EA, Henry ML, Davies EA, Saluzar A, Ferguson RM. Acute rejection episodes - best predictor of long-term primary cadaveric renal transplant survival. Transplant Proc. 1993; 25: 901-2.
10. Almond PS, Matas A, Gillingham K et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752-6.
11. Takemoto S, Terasaki PI, Cecka JM et al. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. N Engl J Med 1992; 327: 834-9.
12. Feehally J, Harris KPG, Bennett SE, Walls J. Is chronic renal transplant rejection a non-immunological phenomenon? Lancet 1986; ii: 486.
13. Isoniemi HM, Ahonen J, Tikkanen MJ et al. Long-term consequences of different immunosuppressive regimens for renal allografts. Transplantation 1993; 55: 494-9.
14. Harper SJ, Moorhouse J, Veitch PS et al. Improved immediate graft function with nifedipine in cyclosporintreated renal allograft recipients - a randomized prospective study. Transplantation 1992; 54: 742-3.
15. Nicholson ML, Attard AR, Bell A, Donnelly PK, Veitch PS, Bell PRF. Renal transplant biopsy using real time ultrasound guidance. Br J Urol 1990; 65: 564-5.
16. Ruiz P, Kolbeck PC, Scroggs MW, Sanfilippo F. Associations between cyclosporine therapy and interstitial fibrosis in renal allograft biopsies. Transplantation 1988; 45: 91-5.
17. Wilczek HE, Groth CG, Bohman S-O. Effect of reduced cyclosporin dosage on long-term renal allograft histology. Transpl Int 1992; 5: 65-70.
18. Hancock WW, Whitley WD, Tullius SG et al. Cytokines, adhesion molecules and the pathogenesis of chronic rejection of rat renal allografts. Transplantation 1993; 56: 643-50.
19. Häyry P, Isoniemi H, Yilmaz S et al. Chronic allograft rejection. Immunol Rev 1993; 134: 33-81.
20. Häyry P, Mennander A, Yilmaz S et al. Towards understanding the pathophysiology of chronic rejection. Clin Investig 1992; 70: 780-90.
21. Fellström BC, Larsson E. Pathogenesis and treatment perspectives of chronic graft rejection (CVR). Immunol Rev 1993; 134: 83-98.
22. Tullius SG, Heemann U, Hancock WW, Azuma H, Tilney NL. Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection. Ann Surg 1994; 220: 425-35.
23. Almond PS, Gillingham KJ, Sibley R et al. Renal transplant function after ten years of cyclosporine. Transplantation 1992; 53: 316-23.
24. Myers BD. Cyclosporine nephrotoxicity. Kidney Int 1986; 30: 964-74.
25. Bignardi G, Neild GH, Hartley RB et al. Histopathological changes in cyclosporine-treated renal allografts at one and twelve months. Nephrol Dial Transplant 1987; 2: 366-70.
26. Savoldi S, Scolari F, Sandrini S et al. Cyclosporine chronic nephrotoxicity: histologic follow-up at 6 and 18 months after renal transplantation. Transplant Proc 1988; 20(Suppl 3): 777-84.
27. d'Ardenne AJ, Dunnill MS, Thompson JF. McWinnie D, Wood RF, Morris PJ. Cyclosporin and renal graft histology. J Clin Pathol 1986; 39: 145-51.
28. Mihatsch MJ, Thiel G, Basler V et al. Morphological patterns in cyclosporine-treated renal transplant recipients. Transplant Proc 1985; 17(Suppl 1): 101-16.
29. Sibley RK, Payne W. Morphologic findings in the renal allograft biopsy. Semin Nephrol 1985; 5: 294-306.
30. Simonton SC, Sibley RK, Fryd DS. A comparison of renal biopsies in cyclosporine and conventionally immuno-suppressed renal transplant recipients. Transplant Proc 1987; 19: 1790.
31. Neild GH, Taube DH, Hartley RB et al. Morphological differentiation between rejection and cyclosporin nephrotoxicity in renal allografts. J Clin Pathol 1986; 39: 152-9.
32. Dieterle A, Gratwohl A, Nizze H et al. Chronic cyclosporine-associated nephrotoxicity in bone marrow transplant patients. Transplantation 1990; 49: 1093-100.
33. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M. Cyclosporine-associated chronic nephropathy. N Engl J Med 1984; 311: 699-705.
34. Myers BD, Sibley R, Newton L et al. The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 1988; 33: 590-600.
35. Svenson K, Bohman S-O, Hallgren R. Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine. Arch Intern Med 1986; 146: 2007-10.
36. Palestine AG, Austin HA III, Balow JE et al. Renal histopathological alterations in patients treated with cyclosporine for uveitis. N Engl J Med 1986; 314: 1293-8.
37. Dieterle A, Abeywickrama K, von Graffenried B. Nephrotoxicity and hypertension in patients with autoimmune disease treated with cyclosporine. Transplant Proc 1988; 20: 349-55.
38. Wolf G, Neilson EG. Increases in levels of collagen types I and IV messenger ribonucleic acid in murine kidneys after treatment with cyclosporin. Nephron 1992; 60: 87-91.